Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Praxis Precision Medicines

Clinical trials sponsored by Praxis Precision Medicines, explained in plain language.

Praxis Precision Medicines PRAX NASDAQ

A clinical-stage biopharmaceutical company developing therapies for central nervous system disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 6 Completed 2

New hope for babies with rare seizure disorder: drug trial targets SCN2A gene

Disease control Recruiting now

This study tests a medicine called elsunersen in 40 children with a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug can safely reduce how often seizures happen over 24 weeks. Children must have started having seizures before 3 mon…

Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC